1 |
Wang R, Tang R, Li B, et al. Gut microbiome, liver immunology, and liver diseases[J]. Cell Mol Immunol, 2021, 18(1): 4-17.
|
2 |
Milosevic I, Vujovic A, Barac A, et al. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature[J]. Int J Mol Sci, 2019, 20(2): 395.
|
3 |
Gomaa EZ. Human gut microbiota/microbiome in health and diseases: a review[J]. Antonie Van Leeuwenhoek, 2020, 113(12): 2019-2040.
|
4 |
Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: pathophysiological basis for therapy[J]. J Hepatol, 2020, 72(3): 558-577.
|
5 |
Albhaisi SAM, Bajaj JS, Sanyal AJ. Role of gut microbiota in liver disease[J]. Am J Physiol Gastrointest Liver Physiol, 2020, 318(1): G84-G98.
|
6 |
Boeri L, Izzo L, Sardelli L, et al. Advanced organ-on-a-chip devices to investigate liver multi-organ communication: focus on gut, microbiota and brain[J]. Bioengineering (Basel), 2019, 6(4): 91.
|
7 |
Suzuki T. Regulation of the intestinal barrier by nutrients: the role of tight junctions[J]. Anim Sci J, 2020, 91(1): e13357.
|
8 |
Chen Y, Cui W, Li X, et al. Interaction between commensal bacteria, immune response and the intestinal barrier in inflammatory bowel disease[J]. Front Immunol, 2021,12:761981.
|
9 |
Yang M, Gu Y, Li L, et al. Bile acid-gut microbiota axis in inflammatory bowel disease: from bench to bedside[J]. Nutrients, 2021, 13(9): 3143.
|
10 |
DiMarzio M, Rusconi B, Yennawar NH, et al. Identification of a mouse Lactobacillus johnsonii strain with deconjugase activity against the FXR antagonist T-β-MCA[J]. PLoS One, 2017, 12(9): e0183564.
|
11 |
于爽,顾志敏,樊亚东,等. 胆汁酸免疫调节作用及其与肠道、肝脏炎症性疾病相关性的研究进展[J]. 中国免疫学杂志,2022, 38(16): 2031-2036.
|
12 |
Xu Z, Jiang N, Xiao Y, et al. The role of gut microbiota in liver regeneration[J]. Front Immunol, 2022, 13:1003376.
|
13 |
Wang H, Xi Z, Deng L, et al. Macrophage polarization and liver ischemia-reperfusion injury[J]. Int J Med Sci, 2021, 18(5): 1104-1113.
|
14 |
Deng F, Lin ZB, Sun QS, et al. The role of intestinal microbiota and its metabolites in intestinal and extraintestinal organ injury induced by intestinal ischemia reperfusion injury[J]. Int J Biol Sci, 2022, 18(10): 3981-3992.
|
15 |
Kato K, Nagao M, Miyamoto K, et al. Longitudinal analysis of the intestinal microbiota in liver transplantation[J]. Transplant Direct, 2017, 3(4):e144.
|
16 |
Hu J, Deng F, Zhao B, et al. Lactobacillus murinus alleviate intestinal ischemia/reperfusion injury through promoting the release of interleukin-10 from M2 macrophages via Toll-like receptor 2 signaling[J]. Microbiome, 2022, 10(1):38.
|
17 |
El-Bendary M, Naemattalah M, Yassen A, et al. Interrelationship between Toll-like receptors and infection after orthotopic liver transplantation[J]. World J Transplant, 2020, 10(6): 162-172.
|
18 |
Rueter C, Bielaszewska M. Secretion and delivery of intestinal pathogenic Escherichia coli virulence factors via outer membrane vesicles[J]. Front Cell Infect Microbiol, 2020, 10: 91.
|
19 |
Wu H, Xie S, Miao J, et al. Lactobacillus reuteri maintains intestinal epithelial regeneration and repairs damaged intestinal mucosa[J]. Gut Microbes, 2020, 11(4): 997-1014.
|
20 |
Kahn J, Pregartner G, Schemmer P. Effects of both pro- and synbiotics in liver surgery and transplantation with special focus on the gut-liver axis-a systematic review and Meta-analysis[J]. Nutrients, 2020, 12(8): 2461.
|
21 |
Kirkpatrick CL, Parsley NC, Bartges TE, et al. Exploring bioactive peptides from bacterial secretomes using PepSAVI-MS: identification and characterization of Bac-21 from Enterococcus faecalis pPD1[J]. Microb Biotechnol, 2018, 11(5): 943-951.
|
22 |
Ronca V, Wootton G, Milani C, et al. The immunological basis of liver allograft rejection[J]. Front Immunol, 2020, 11: 2155.
|
23 |
Liu Y, Pu X, Qin X, et al. Neutrophil extracellular traps regulate HMGB1 translocation and kupffer cell M1 polarization during acute liver transplantation rejection[J]. Front Immunol, 2022, 13: 823511.
|
24 |
Ren Z, Jiang J, Lu H, et al. Intestinal microbial variation may predict early acute rejection after liver transplantation in rats[J]. Transplantation, 2014, 98(8): 844-852.
|
25 |
Lee SK, Jhun JY, Lee SY, et al. A decrease in functional microbiomes represented as Faecalibacterium affects immune homeostasis in long-term stable liver transplant patients[J]. Gut Microbes, 2022, 14(1): 2102885.
|
26 |
Nemes B, Gámán G, Doros A. Biliary complications after liver transplantation[J]. Expert Rev Gastroenterol Hepatol, 2015, 9(4): 447-466.
|
27 |
Wang SF, Huang ZY, Chen XP. Biliary complications after living donor liver transplantation[J]. Liver Transpl, 2011, 17(10): 1127-1136.
|
28 |
Zuhair M, Smit GSA, Wallis G, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis[J]. Rev Med Virol, 2019, 29(3): e2034.
|
29 |
Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host[J]. Nat Rev Microbiol, 2021, 19(12): 759-773.
|
30 |
Le-Trilling VTK, Ebel JF, Baier F, et al. Acute cytomegalovirus infection modulates the intestinal microbiota and targets intestinal epithelial cells[J]. Eur J Immunol, 2023, 53(2): e2249940.
|
31 |
Georges P, Clerc C, Turco C, et al. Post-transplantation cytomegalovirus infection interplays with the development of anastomotic biliary strictures after liver transplantation[J]. Transpl Int, 2022, 35: 10292.
|
32 |
Makino K, Ishii T, Yoh T, et al. The usefulness of preoperative bile cultures for hepatectomy with biliary reconstruction[J]. Heliyon, 2022, 8(12): e12226.
|
33 |
Wong HJ, Lim WH, Ng CH, et al. Predictive and prognostic roles of gut microbial variation in liver transplant[J]. Front Med, 2022, 9: 873523.
|
34 |
Ma HD, Zhao ZB, Ma WT, et al. Gut microbiota translocation promotes autoimmune cholangitis[J]. J Autoimmun, 2018, 95: 47-57.
|
35 |
邬兴炳. 围手术期肠道微生态干预在肝移植术后腹腔感染防治中的应用[D]. 浙江:宁波大学,2019.
|
36 |
Chen Y, Tsai YH, Tseng BJ, et al. Influence of growth hormone and glutamine on intestinal stem cells: a narrative review[J]. Nutrients, 2019, 11(8): 1941.
|